Smartphone rehab after breast cancer surgery shows promise
NCT ID NCT06156397
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tested whether technology-based rehabilitation (telerehabilitation or a mobile app) could improve arm and shoulder function after breast cancer surgery, compared to standard physiotherapy. 45 women who had surgery with lymph node removal participated. The goal was to see if remote or app-based exercise programs could help recovery just as well as in-person sessions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Technological based rehabilitation (telerehabilitation and mobile application supported exercise program)
- What this could lead to
- If successful, this could show that remote or app-based rehab is as effective as in-person physiotherapy for recovery after breast cancer surgery.
- What could go wrong
- This is a small, completed study with only 45 participants, so results may not apply to everyone. The interventions are compared to standard care, not a placebo, and the primary outcome is range of motion, not long-term function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
45 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Feb 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being diagnosed with breast cancer and undergoing surgery and having axillary lymph node dissection performed during surgery * Finding the cases in the post-operative (post-op) 2nd week * Age range between 30 and 65 years * Limited shoulder ROM in preoperative evaluations absence * No speech or hearing problems * Patients included in the study are volunteers Exclusion Criteria: * Previous ipsilateral or contralateral breast cancer surgery * Presence of active or metastatic cancer focus * A neurological disease that affects upper extremity functionality or * Finding orthopedic surgery * Having hearing or visual impairment * Carrying a pacemaker * Presence of infection and open wound * Finding a drain after surgery * Cases with mental and cooperation problems
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Health Sciences Haydarpaşa Numune Hospital
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?